Evidence map›Paper›PMID 37586744›Full record

ArticleThorax2023

Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.

Patrick Goodley, Haval Balata, Alberto Alonso, Christopher Brockelsby, Matthew Conroy, Nicola Cooper-Moss, Christopher Craig, Matthew Evison, Kath Hewitt, Coral Higgins and 9 more

Abstract read
In one paragraph

Article in Thorax, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Patrick GoodleyDivision of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, UK.ORCID 0000-0002-5729-2548
Haval BalataDivision of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, UK.ORCID 0000-0002-8596-9376
Alberto AlonsoManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Christopher BrockelsbyManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Matthew ConroyManchester Integrated Care Partnership (NHS Greater Manchester), Manchester, UK.
Nicola Cooper-MossCentre for Primary Care, The University of Manchester, Manchester, UK.ORCID 0000-0003-0527-6287
Christopher CraigManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Matthew EvisonManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.ORCID 0000-0003-4066-5253
Kath HewittManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Coral HigginsManchester Integrated Care Partnership (NHS Greater Manchester), Manchester, UK.
William JohnsonFaculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Judith LyonsManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Zoe MerchantManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.ORCID 0000-0001-6217-2973
Ailsa RowlandsManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Anna SharmanManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Nicola SinnottManchester Thoracic Oncology Centre (MTOC), Manchester University NHS Foundation Trust, Manchester, UK.
Matthew SperrinDivision of Informatics Imaging and Data Sciences, The University of Manchester, Manchester, UK.ORCID 0000-0002-5351-9960
Richard BootonDivision of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, UK.ORCID 0000-0003-4512-2899
Philip A J CrosbieDivision of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, UK philip.crosbie@manchester.ac.uk.ORCID 0000-0001-8941-4813

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough lung cancer screening is being implemented in the UK, there is uncertainty about the optimal invitation strategy. Here, we report participation in a community screening programme following a population-based invitation approach, examine factors associated with participation, and compare outcomes with hypothetical targeted invitations.

methodsLetters were sent to all individuals (age 55-80) registered with a general practice (n=35 practices) in North and East Manchester, inviting ever-smokers to attend a Lung Health Check (LHC). Attendees at higher risk (PLCO

resultsLetters were sent to 35 899 individuals, 71% from the most socioeconomically deprived quintile. Estimated response rate in ever-smokers was 49%; a lower response rate was associated with younger age, male sex, and primary care recorded current smoking status ( DISCUSSION: Using a population-based invitation strategy, in an area of high socioeconomic deprivation, is effective and may increase screening accessibility. Due to limitations in primary care records, targeted approaches should incorporate historical smoking codes and individuals with absent smoking records.

Indexed as

Early Detection of CancerLung NeoplasmsAgedAged, 80 and overHumansMaleMass ScreeningMiddle AgedSmokersSmokingSocioeconomic FactorsClinical EpidemiologyLung Cancer

Identifiers

PMID37586744
PMCPMC10803959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.